mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
ML312 |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.7 |
mRNA |
BRD-K04800985 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
BRD-K44224150 |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.7 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.0093 |
0.7 |
mRNA |
VX-680 |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.7 |